Comparison and review of updated guidelines for advanced gastric cancer diagnosis and treatment in 2024: CSCO, NCCN and ESMO
Gastric cancer is a highly prevalent and aggressive malignancy worldwide, with generally poor prognosis. There are differences in epidemiology, clinicopathological characteristics, treatment modalities, and drug selection for gastric cancer between Eastern and Western populations. Recent advancement...
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Editorial Office of China Oncology
2025-02-01
|
| Rangatū: | Zhongguo aizheng zazhi |
| Ngā marau: | |
| Urunga tuihono: | http://www.china-oncology.com/fileup/1007-3639/PDF/1742381075389-549581150.pdf |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|